Difference between revisions of "Measures of strength of association"

From WikiVet English
Jump to navigation Jump to search
Line 24: Line 24:
 
In the case of a [[Study design#Cross sectional studies|cross sectional study]], the '''[[Measures of disease frequency#Prevalence|prevalence]]''' can be estimated amongst exposed individuals as (a<sub>1</sub>/n<sub>1</sub>), and amongst unexposed individuals as (a<sub>0</sub>/n<sub>0</sub>).<br>
 
In the case of a [[Study design#Cross sectional studies|cross sectional study]], the '''[[Measures of disease frequency#Prevalence|prevalence]]''' can be estimated amongst exposed individuals as (a<sub>1</sub>/n<sub>1</sub>), and amongst unexposed individuals as (a<sub>0</sub>/n<sub>0</sub>).<br>
  
In the case of a [[Study design#Cohort studies|cohort study]] or a [[Study design#Experimental studies|randomised controlled trial]], and assuming that the disease status relates only to ''new'' cases of disease, the '''[[Measures of disease frequency#Incidence risk|incidence risk]]''' can be estimated amongst exposed individuals as (a<sub>1</sub>/n<sub>1</sub>), and amongst unexposed individuals as (a<sub>0</sub>/n<sub>0</sub>). Alternatively, the [[Measures of disease frequency#Incidence rate|incidence rate]] can be estimated, if the total animal-time for each exposure group is known, as (a<sub>1</sub>/[total number of animal-time units in exposed group]) amongst exposed animals and (a<sub>1</sub>/[total number of animal-time units in unexposed group]) amongst unexposed animals.<br>
+
In the case of a [[Study design#Cohort studies|cohort study]] or a [[Study design#Experimental studies|experimental study]], the disease status of individuals will relate only to ''new'' cases of disease (i.e. those which were not diseased at the start of the study. In these cases, the '''[[Measures of disease frequency#Incidence risk|incidence risk]]''' can be estimated amongst exposed individuals as (a<sub>1</sub>/n<sub>1</sub>), and amongst unexposed individuals as (a<sub>0</sub>/n<sub>0</sub>). Alternatively, the [[Measures of disease frequency#Incidence rate|incidence rate]] can be estimated, if the total animal-time for each exposure group is known, as (a<sub>1</sub>/[total number of animal-time units in exposed group]) amongst exposed animals and (a<sub>1</sub>/[total number of animal-time units in unexposed group]) amongst unexposed animals.<br>
  
In the case of a [[Study design#Case control studies|case control study]], no [[Measures of disease frequency|measures of disease frequency]] can be calculated, as selection of individuals was based upon their disease status. However, the '''odds of exposure''' can be estimated amongst diseased individuals as (a<sub>1</sub>/a<sub>0</sub>), and amongst nondiseased individuals as (b<sub>1</sub>/b<sub>0</sub>).<br>
+
In the case of a [[Study design#Case control studies|case control study]], no [[Measures of disease frequency|measures of disease frequency]] can be calculated, as selection of individuals was based upon their disease status. However an analytic study can still be conducted. This is achieved by looking at the '''odds of exposure''' in the different disease groups. It can be shown that (as long as the ''[[Sampling strategies#Sampling fraction|sampling fraction]]'' is different for cases than controls), the exposure odds ratio comparing diseased to non diseased animals is identical to the odds ratio for disease, comparing exposed to nonexposed animals. The odds ratio amongst diseased individuals is calculated as (a<sub>1</sub>/a<sub>0</sub>), and amongst nondiseased individuals as (b<sub>1</sub>/b<sub>0</sub>).<br>
  
  

Revision as of 07:38, 5 May 2011

Analytic studies are conducted in an attempt to identify whether the disease experience in a population differs between groups of animals within this population (defined by exposure to 'risk factors' of interest), in the hope that some indication of a causal association can be achieved. Therefore, methods are required in order to quantify any 'evidence' in support of a possible association. Epidemiologists commonly measure this using measures of strength of association and through the use of null hypothesis tests. It is important to use both of these measures whenever interpreting the results of an analytic study, as they measure different things. Measures of strength of association are an indication of the magnitude of the association, whereas the hypothesis test results give an indication of the probability of seeing the data obtained if there was no association between the exposure and outcome in the source population.

Correlation coefficients

Correlation coefficients are used when comparing two quantitative variables, and are based upon the covariance between these variables amongst the individuals in the study population. Strictly speaking, the covariance is a measure of how two variables differ in individuals in relation to their mean values in the whole population - or put more simply, it is a measure of how the variables change in relation to each other. As the magnitude of the covariance will depend upon the magnitudes of the variables in question, this value is 'standardised' in order to give a correlation coefficient, which lies between -1 (indicating a perfect negative correlation) and +1 (indicating a perfect positive correlation). A coefficient of 0 indicates no correlation, and therefore correlation coefficients are a useful measure of the strength of association between quantitative variables.

Ratio measures

Although correlation coefficients are commonly used in statistical studies, epidemiological investigations often deal with binary exposures and outcomes (such as presence or absence of a proposed risk factor for disease, and presence or absence of disease itself). Therefore, ratio measures such as the prevalence ratio, the risk ratio, the rate ratio and the odds ratio are commonly used as measures of strength of association in epidemiological studies.

Understanding how these measures are calculated is best approached using a contingency table (also known as a cross tabulation), as shown below. In this table, the columns divide all individuals into exposed and unexposed, whilst the rows divide individuals into those who are diseased and those who are not diseased. Therefore, cell 'm1' represents all diseased individuals, cell 'n1' represents all exposed individuals, and cell 'a1' represents exposed individuals who are also diseased.

Disease status Exposed Unexposed Total
Diseased a1 a0 m1
Non-diseased b1 b0 m0
Total n1 n0 n

The measures of disease frequency which can be extracted from this table will depend on the study design used, which will be analytic in nature, as data regarding exposure have been collected.

In the case of a cross sectional study, the prevalence can be estimated amongst exposed individuals as (a1/n1), and amongst unexposed individuals as (a0/n0).

In the case of a cohort study or a experimental study, the disease status of individuals will relate only to new cases of disease (i.e. those which were not diseased at the start of the study. In these cases, the incidence risk can be estimated amongst exposed individuals as (a1/n1), and amongst unexposed individuals as (a0/n0). Alternatively, the incidence rate can be estimated, if the total animal-time for each exposure group is known, as (a1/[total number of animal-time units in exposed group]) amongst exposed animals and (a1/[total number of animal-time units in unexposed group]) amongst unexposed animals.

In the case of a case control study, no measures of disease frequency can be calculated, as selection of individuals was based upon their disease status. However an analytic study can still be conducted. This is achieved by looking at the odds of exposure in the different disease groups. It can be shown that (as long as the sampling fraction is different for cases than controls), the exposure odds ratio comparing diseased to non diseased animals is identical to the odds ratio for disease, comparing exposed to nonexposed animals. The odds ratio amongst diseased individuals is calculated as (a1/a0), and amongst nondiseased individuals as (b1/b0).